Skip to main content.
Menu

Putting Valley Fever on the Front Burner

Changing Climate May Expand Valley Fever's Impact

Fellowship Story Showcase

Putting Valley Fever on the Front Burner

How do patient groups call attention to the need for research on promising treatments? One distinguished researcher suggests following the strategy of AIDS research advocates, or, as she puts it, "Going HIV."

Sunday, September 9, 2012

By

Reporting on Health Collaborative

How does knowledge about unfamiliar diseases enter the public consciousness and the public policy agenda?

As editor of Reporting on Health, I’ve been doing a lot of thinking about this question as we launch a series by a new reporting collaborative I brought together. It includes news outlets whose reporters have participated in our Reporting on Health Contributing Editor William Heisel has ably served as project editor for this effort.

chronicles the terrible toll of valley fever, a disease found throughout the Southwest, including California’s San Joaquin Valley. Valley fever has reached epidemic levels in California's Central Valley. It is woven through the fabric of people’s lives – everyone there knows someone with the disease – but it receives woefully little attention from policy makers, researchers and public health officials.

This devastating disease can be contracted when fungal spores lodge in the lungs after being swept up from the dirt by wind. Valley fever, or coccidioidomycosis, strikes more than 150,000 people nationally each year. In about 100 cases annually, the disease kills.

The news media perform their most fundamental public service by highlighting overlooked community concerns.  Local reporters and editors involved with the Collaborative identified valley fever as a topic worthy of sustained and concentrated reporting attention. Stories on the issue will appear beginning Saturday, September 8 and continue as an occasional series over the next month in the Bakersfield Californian; the Merced Sun-Star; Radio Bilingüe; The Record in Stockton, Valley Public Radio and Vida en el Valle in Fresno; and the Voice of OC in Santa Ana.  The stories also can all be found on our project micro-site on Reporting on Health.

Our Reporting on Health Collaborative found that valley fever causes more deaths than Hantavirus, hepatitis A, whooping cough and salmonella poisoning combined, yet all of these conditions are more widely known. Among my friends, for instance, everyone began talking about the hantavirus threat after the California Department of Public Health put out an advisory about cases in Yosemite National Park. News outlets all over the country then picked up that bulletin.  Yet the incidence of Hantavirus – with eight confirmed cases and three deaths among Yosemite visitors as of this writing – pales in comparison with valley fever.

Competition for research dollars

Valley fever also receives only a fraction of the research funding that many other diseases receive. But valley fever isn’t the only ailment that has received the short end of the stick,

www.reportingonhealth.org/valleyfever

when it comes to research and public health attention. Journalist Tara Parker-Pope of the New York Times has written that lung cancer is “the big loser” in the cancer funding race despite taking an enormous toll as the country’s biggest cancer killer, with triple the deaths caused by rectal and colon cancer and quadruple the deaths caused by breast cancer, according to federal data.

The winners of the research funding race include West Nile disease. The federal government spent on research on the disease in 2010, a year in which there were 1,021 cases and for a per death investment of $912,280. That same year, it for research on cardiovascular disease, which killed  Americans, according to preliminary data from the CDC, for a per death investment of $426. Heart disease is the leading cause of death in America.

But diseases like West Nile virus or hantavirus intrigue. Hantavirus seems exotic and newsworthy and provokes a profound sense of alarm because it is so fatal, novel and unexpected, theorizes Alexander Capron, my USC colleague and the Scott H. Bice Chair in Healthcare Law, Policy and Ethics. The prominence of the victims can be just as important when it comes to garnering public attention for a disease, he adds. So it’s not that surprising that California’s Central Valley, often overlooked in favor of urban centers, wouldn’t get needed policy attention around this issue.

We hope that the series helps those who suffer from the disease to feel less alone. Community can be healing and empowering. And when it comes to commanding resources for prevention or research, it can serve as a potent force for change.

“There is a vicious cycle of a disease not getting funding because it is not hitting a vocal or connected group of people,” Dr. Francine Kaufman, M.D. told me.  A pediatric endocrinologist who is vice president of global medical affairs for Medtronic, Inc., she has had a distinguished career as a researcher, clinician and activist focused on diabetes in children.

 “It needs a group to lobby for it, a patient association.  The term is ‘to go HIV,’” she adds, “which means get all the people who have it or are at risk to make noise.  This is what happens in cancer and diabetes.  I don’t think there is a well-connected cocci patient group out there up in arms.  The Central Valley is low on the totem pole for everything in this state and country.”

Starting a community conversation

We are taking Dr. Kaufman’s advice to heart. Our aim with this series is to start a community conversation around what needs to be done in public health and policy circles about valley fever. There is a role for everyone ranging from concerned locals to patients to health care providers, businesses and farm interests, community groups and non-profits.

Iso.in.ua, which funds our programs, including the Reporting on Health Collaborative, is encouraging this new direction. Mary Lou Fulton, a senior program manager, had a distinguished history as an innovator in community media before entering the foundation world. She finds great value in thinking of the publication of journalistic projects as a starting point not an end point.

We are learning as we seek to connect with community leaders in the San Joaquin Valley. And we are relying on the wisdom of friends, thinkers like who has built a potent community around diabetes with , an international online community for people with diabetes. At a recent forum, Donna Hill, chair of the foundation board that governs the Tu Diabetes site, shared how she organized her friends from Tu Diabetes to successfully prod a major pharmaceutical company to renew its effort to take a promising diabetes treatment to market. It had placed that project on the back burner.

“Social networks no longer serve 'just' to keep us up-to-date about our friends and family,” Hernandez told me. “They have become agents of change, helping galvanize people around causes, from diabetes to cancer. There is growing evidence of the impact and improved outcomes that can be seen when people touched by the same medical condition connect with each other."

 Or, as Susannah Fox put it to me, after studying online patient communities for years as associate director of digital strategy for the Pew Internet and American Life Project: “Altruism can scale.”

----------

Michelle Levander is the founding editor of Center for Health Journalism Digital and director of Iso.in.ua Health Journalism Fellowships at the USC Annenberg School of Jounalism.You can reach her at [email protected] 

 Photo credit: Vida en el Valle

About This Series

This project results from an innovative reporting venture – the Center for Health Journalism Collaborative – which currently involves the Bakersfield Californian, Radio Bilingüe in Fresno, Valley Public Radio in Fresno and Bakersfield, Vida en el Valle in Fresno, Hanford Sentinel, the Voice of OC in Santa Ana, the Arizona Daily Star in Tucson, La Estrella de Tucsón and the Center for Health Journalism. The collaborative is an initiative of the Center for Health Journalism at the University of Southern California’s Annenberg School for Communication and Journalism.

RELATED STORIES

Valley fever medication poses added risk for pregnant women

Research suggests an alarming link between a common drug used for valley fever and birth defects. The disease also tends to be more severe in pregnant women.

Legislation caps momentous year in battle against valley fever

Recently signed legislation capped a big year for efforts to combat a regional disease long overlooked by lawmakers.

For valley fever survivors, a growing need: wigs

The antifungal drugs used to treat valley fever can cause hair loss. With the number of valley fever cases on the rise, a wig shop in Bakersfield, Calif., is helping women feel better about themselves.

California budget boosts funding for valley fever

The budget includes $8 million for research and outreach into the disease, caused by inhaling spores that grow in arid soil.

Three valley fever bills sail through committee, one pulled by sponsor

Facing pushback from the medical community, California Assemblyman Vince Fong withdrew a bill late last month that would have required doctors to order specific types of lab tests when they suspect valley fever.

Assemblymen ask state for $7 million in fight against valley fever to fuel research, spread awareness

Bakersfield Assemblymen Vince Fong and Rudy Salas submitted a $7 million budget proposal that, if approved, would be the largest amount of money California has ever designated to research and raise awareness of the disease.

One year after federal health officials launch first-of-its-kind valley fever drug trial, few have enrolled

Just 48 people have signed up across California and Arizona for a new clinical trial of Fluconazole, an antifungal drug used to treat valley fever. That's far fewer than officials had expected.

Bakersfield legislators ask state for $3M in fight against valley fever

Bakersfield lawmakers requested $3 million in the state budget last week to research treatments and conduct outreach for valley fever.
steroid-pharm.com

steroid-pharm.com/ghrp-6-10-mg.html

https://best-mining.com.ua